Brickell Historical Income Statement

BBI Stock  USD 0.90  0.02  2.27%   
Historical analysis of Brickell Biotech income statement accounts such as Interest Expense of 75.4 K, Selling General Administrative of 10.6 M or Total Revenue of 441.4 K can show how well Brickell Biotech performed in making a profits. Evaluating Brickell Biotech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Brickell Biotech's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Brickell Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Brickell Biotech is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.

About Brickell Income Statement Analysis

Brickell Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Brickell Biotech shareholders. The income statement also shows Brickell investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Brickell Biotech Income Statement Chart

Brickell Biotech Income Statement is one of the three primary financial statements used for reporting Brickell's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Brickell Biotech revenue and expense. Brickell Biotech Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Brickell Biotech's Cost Of Revenue is increasing as compared to previous years. The Brickell Biotech's current Interest Income is estimated to increase to about 2.1 M, while Depreciation And Amortization is projected to decrease to under 24 K.

Total Revenue

Total revenue comprises all receipts Brickell Biotech generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Brickell Biotech. It is also known as Brickell Biotech overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Brickell Biotech income statement and represents the costs associated with goods and services Brickell Biotech provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most accounts from Brickell Biotech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Brickell Biotech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.As of now, Brickell Biotech's Cost Of Revenue is increasing as compared to previous years. The Brickell Biotech's current Interest Income is estimated to increase to about 2.1 M, while Depreciation And Amortization is projected to decrease to under 24 K.
 2023 2024 (projected)
Total Operating Expenses46.7M29.0M
Cost Of Revenue23.2M24.4M

Brickell Biotech income statement Correlations

-0.360.580.80.520.370.410.390.44-0.430.060.44-0.070.4-0.23-0.39-0.060.58-0.3-0.750.85-0.41
-0.36-0.2-0.18-0.01-0.2-0.060.020.00.04-0.070.010.5-0.020.810.05-0.07-0.050.890.18-0.4-0.59
0.58-0.20.380.180.77-0.23-0.24-0.20.120.62-0.15-0.17-0.23-0.22-0.04-0.58-0.01-0.2-0.260.35-0.16
0.8-0.180.380.850.270.60.580.62-0.380.00.6-0.030.59-0.12-0.35-0.210.64-0.16-0.630.74-0.51
0.52-0.010.180.850.110.470.460.49-0.190.040.460.020.460.0-0.14-0.210.38-0.05-0.360.45-0.41
0.37-0.20.770.270.11-0.53-0.55-0.510.430.91-0.49-0.3-0.54-0.290.5-0.73-0.35-0.270.10.030.11
0.41-0.06-0.230.60.47-0.530.990.99-0.78-0.760.960.191.00.09-0.80.460.940.04-0.730.71-0.54
0.390.02-0.240.580.46-0.550.991.0-0.8-0.770.970.281.00.19-0.80.440.940.14-0.730.68-0.59
0.440.0-0.20.620.49-0.510.991.0-0.81-0.740.970.271.00.17-0.810.420.950.12-0.760.72-0.6
-0.430.040.12-0.38-0.190.43-0.78-0.8-0.810.64-0.84-0.54-0.8-0.340.72-0.42-0.82-0.250.9-0.70.52
0.06-0.070.620.00.040.91-0.76-0.77-0.740.64-0.7-0.27-0.76-0.210.74-0.72-0.65-0.170.39-0.280.26
0.440.01-0.150.60.46-0.490.960.970.97-0.84-0.70.280.970.18-0.80.40.930.14-0.790.71-0.61
-0.070.5-0.17-0.030.02-0.30.190.280.27-0.54-0.270.280.260.91-0.26-0.070.260.83-0.38-0.07-0.33
0.4-0.02-0.230.590.46-0.541.01.01.0-0.8-0.760.970.260.15-0.810.440.940.1-0.740.7-0.56
-0.230.81-0.22-0.120.0-0.290.090.190.17-0.34-0.210.180.910.15-0.14-0.080.130.98-0.16-0.25-0.49
-0.390.05-0.04-0.35-0.140.5-0.8-0.8-0.810.720.74-0.8-0.26-0.81-0.14-0.33-0.86-0.110.71-0.620.47
-0.06-0.07-0.58-0.21-0.21-0.730.460.440.42-0.42-0.720.4-0.070.44-0.08-0.330.32-0.11-0.230.25-0.12
0.58-0.05-0.010.640.38-0.350.940.940.95-0.82-0.650.930.260.940.13-0.860.320.09-0.840.79-0.62
-0.30.89-0.2-0.16-0.05-0.270.040.140.12-0.25-0.170.140.830.10.98-0.11-0.110.09-0.07-0.3-0.53
-0.750.18-0.26-0.63-0.360.1-0.73-0.73-0.760.90.39-0.79-0.38-0.74-0.160.71-0.23-0.84-0.07-0.880.56
0.85-0.40.350.740.450.030.710.680.72-0.7-0.280.71-0.070.7-0.25-0.620.250.79-0.3-0.88-0.5
-0.41-0.59-0.16-0.51-0.410.11-0.54-0.59-0.60.520.26-0.61-0.33-0.56-0.490.47-0.12-0.62-0.530.56-0.5
Click cells to compare fundamentals

Brickell Biotech Account Relationship Matchups

Brickell Biotech income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization151K28K10K22K25.3K24.0K
Selling General Administrative8.9M12.2M11.6M12.4M11.2M10.6M
Total Revenue1.6M7.9M1.8M404K464.6K441.4K
Gross Profit186K7.9M1.8M404K464.6K441.4K
Other Operating Expenses22.7M32.4M22.8M40.6M46.7M31.7M
Operating Income(19.6M)(24.5M)(21.0M)(39.4M)(35.5M)(33.7M)
Ebit(15.2M)(21.8M)(20.9M)(39.4M)(35.5M)(33.7M)
Ebitda(15.0M)(21.8M)(20.9M)(39.4M)(35.4M)(33.7M)
Total Operating Expenses21.3M32.4M22.8M40.6M46.7M29.0M
Income Before Tax(16.3M)(23.9M)(20.9M)(39.5M)(45.4M)(47.7M)
Total Other Income Expense Net3.4M591K63K(69K)(62.1K)(59.0K)
Net Income(16.3M)(23.9M)(20.9M)(39.5M)(35.6M)(33.8M)
Income Tax Expense4.5M2.7M63K69K62.1K59.0K
Research Development12.3M20.2M11.2M28.2M32.5M19.2M
Net Income From Continuing Ops(16.3M)(23.9M)(20.9M)(39.5M)(35.5M)(33.8M)
Net Income Applicable To Common Shares(16.3M)(13.6M)(20.9M)(39.5M)(35.5M)(33.8M)
Non Operating Income Net Other426K3.4M2.7M63K72.5K68.8K
Reconciled Depreciation151K28K10K22K19.8K18.8K
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brickell Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brickell Biotech's short interest history, or implied volatility extrapolated from Brickell Biotech options trading.

Pair Trading with Brickell Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving against Brickell Stock

  0.69DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.45MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.44MESO Mesoblast TrendingPairCorr
  0.43VAXX Vaxxinity Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.
The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Brickell Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brickell Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brickell Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brickell Biotech Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.
Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.42)
Revenue Per Share
1.94
Quarterly Revenue Growth
27.576
Return On Assets
(0.80)
Return On Equity
(1.57)
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.